Prevalence of Multimorbidity in Lithuania: Insights from National Health Insurance Fund Data
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Database
2.2. Study Cohort
2.3. Statistical Analysis
3. Results
3.1. Study Cohort Characteristics
3.2. The Prevalence of Chronic Conditions and Their Impact on Healthcare Utilization
3.3. The Prevalence of Multimorbidity and Its Impact on Healthcare Utilization
4. Discussion
4.1. The Rising Prevalence of Multiple Chronic Conditions
4.2. Cardiovascular Diseases Impact on Prevalence of Multimorbidity
4.3. Healthcare Utilization
4.4. Study Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- World Health Organization. Multimorbidity. Available online: https://www.who.int/publications/i/item/9789241511650 (accessed on 13 December 2016).
- Nguyen, H.; Manolova, G.; Daskalopoulou, C.; Vitoratou, S.; Prince, M.; Prina, A.M. Prevalence of Multimorbidity in Community Settings: A Systematic Review and Meta-Analysis of Observational Studies. J. Comorbidity 2019, 9, 2235042X19870934. [Google Scholar] [CrossRef] [PubMed]
- Chowdhury, S.R.; Chandra Das, D.; Sunna, T.C.; Beyene, J.; Hossain, A. Global and Regional Prevalence of Multimorbidity in the Adult Population in Community Settings: A Systematic Review and Meta-Analysis. eClinicalMedicine 2023, 57, 101860. [Google Scholar] [CrossRef] [PubMed]
- Kone, A.P.; Mondor, L.; Maxwell, C.; Kabir, U.S.; Rosella, L.C.; Wodchis, W.P. Rising Burden of Multimorbidity and Related Socio-Demographic Factors: A Repeated Cross-Sectional Study of Ontarians. Can. J. Public Health 2021, 112, 737–747. [Google Scholar] [CrossRef] [PubMed]
- Ho, I.S.-S.; Azcoaga-Lorenzo, A.; Akbari, A.; Davies, J.; Hodgins, P.; Khunti, K.; Kadam, U.; Lyons, R.; McCowan, C.; Mercer, S.W.; et al. Variation in the Estimated Prevalence of Multimorbidity: Systematic Review and Meta-Analysis of 193 International Studies. BMJ Open 2022, 12, e057017. [Google Scholar] [CrossRef]
- Barnett, K.; Mercer, S.W.; Norbury, M.; Watt, G.; Wyke, S.; Guthrie, B. Epidemiology of Multimorbidity and Implications for Health Care, Research, and Medical Education: A Cross-Sectional Study. Lancet 2012, 380, 37–43. [Google Scholar] [CrossRef]
- Forman, D.E.; Maurer, M.S.; Boyd, C.; Brindis, R.; Salive, M.E.; Horne, F.M.; Bell, S.P.; Fulmer, T.; Reuben, D.B.; Zieman, S.; et al. Multimorbidity in Older Adults with Cardiovascular Disease. J. Am. Coll. Cardiol. 2018, 71, 2149–2161. [Google Scholar] [CrossRef]
- Visseren, F.L.J.; Mach, F.; Smulders, Y.M.; Carballo, D.; Koskinas, K.C.; Bäck, M.; Benetos, A.; Biffi, A.; Boavida, J.-M.; Capodanno, D.; et al. 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 2021, 42, 3227–3337. [Google Scholar] [CrossRef]
- Liu, J.; Ma, J.; Wang, J.; Zeng, D.D.; Song, H.; Wang, L.; Cao, Z. Comorbidity Analysis According to Sex and Age in Hypertension Patients in China. Int. J. Med. Sci. 2016, 13, 99–107. [Google Scholar] [CrossRef]
- Navickas, R.; Visockienė, Ž.; Puronaitė, R.; Rukšėnienė, M.; Kasiulevičius, V.; Jurevičienė, E. Prevalence and Structure of Multiple Chronic Conditions in Lithuanian Population and the Distribution of the Associated Healthcare Resources. Eur. J. Intern. Med. 2015, 26, 160–168. [Google Scholar] [CrossRef]
- Lithuania Country Health Profile 2019. The State of Health in the EU. Available online: https://Eurohealthobservatory.Who.Int/Publications/m/Lithuania-Country-Health-Profile-2019 (accessed on 14 November 2019).
- Lithuanian Open Data Portal. Number of Permanent Residents at the Beginning of the Year. Available online: https://data.gov.lt/datasets/2689/ (accessed on 18 June 2024).
- R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2024; Available online: https://www.r-project.org/ (accessed on 29 December 2024).
- Jackman, S. Pscl: Classes and Methods for R Developed in the Political Science Computational Laboratory. R Package, version 1.5.9; University of Sydney: Sydney, Australia, 2024. Available online: https://github.com/atahk/pscl/ (accessed on 29 December 2024).
- Zeileis, A.; Kleiber, C.; Jackman, S. Regression Models for Count Data in R. J. Stat. Softw. 2008, 27, 1–25. Available online: http://www.jstatsoft.org/article/view/v027i08 (accessed on 29 December 2024). [CrossRef]
- Koné Pefoyo, A.J.; Bronskill, S.E.; Gruneir, A.; Calzavara, A.; Thavorn, K.; Petrosyan, Y.; Maxwell, C.J.; Bai, Y.; Wodchis, W.P. The Increasing Burden and Complexity of Multimorbidity. BMC Public Health 2015, 15, 415. [Google Scholar] [CrossRef] [PubMed]
- Jürisson, M.; Pisarev, H.; Uusküla, A.; Lang, K.; Oona, M.; Kalda, R. Prevalence of Chronic Conditions and Multimorbidity in Estonia: A Population-Based Cross-Sectional Study. BMJ Open 2021, 11, e049045. [Google Scholar] [CrossRef] [PubMed]
- Ji, E.; Ahn, S.; Choi, J.-Y.; Kim, C.-H.; Kim, K. Effect of Multimorbidity on Hypertension Management. Sci. Rep. 2023, 13, 18764. [Google Scholar] [CrossRef] [PubMed]
- Jankovic, J.; Mirkovic, M.; Jovic-Vranes, A.; Santric-Milicevic, M.; Terzic-Supic, Z. Association between Non-Communicable Disease Multimorbidity and Health Care Utilization in a Middle-Income Country: Population-Based Study. Public Health 2018, 155, 35–42. [Google Scholar] [CrossRef] [PubMed]
- Kiliari, N.; Theodosopoulou, E.; Papanastasiou, E. Multimorbidity and Unmet Citizens’ Needs and Expectations Urge for Reforms in the Health System of Cyprus: A Questionnaire Survey. JRSM Open 2014, 5, 2042533313515860. [Google Scholar] [CrossRef]
- Zhong, Y.; Qin, G.; Xi, H.; Cai, D.; Wang, Y.; Wang, T.; Gao, Y. Prevalence, Patterns of Multimorbidity and Associations with Health Care Utilization among Middle-Aged and Older People in China. BMC Public Health 2023, 23, 537. [Google Scholar] [CrossRef]
- Lai, F.T.T.; Wong, S.Y.S.; Yip, B.H.K.; Guthrie, B.; Mercer, S.W.; Chung, R.Y.; Chung, G.K.K.; Chau, P.Y.K.; Wong, E.L.Y.; Woo, J.; et al. Multimorbidity in Middle Age Predicts More Subsequent Hospital Admissions than in Older Age: A Nine-Year Retrospective Cohort Study of 121,188 Discharged In-Patients. Eur. J. Intern. Med. 2019, 61, 103–111. [Google Scholar] [CrossRef]
- Zhang, X.; Padhi, A.; Wei, T.; Xiong, S.; Yu, J.; Ye, P.; Tian, W.; Sun, H.; Peiris, D.; Praveen, D.; et al. Community Prevalence and Dyad Disease Pattern of Multimorbidity in China and India: A Systematic Review. BMJ Glob. Health 2022, 7, e008880. [Google Scholar] [CrossRef]
- Jin, Y.; Liang, J.; Hong, C.; Liang, R.; Luo, Y. Cardiometabolic Multimorbidity, Lifestyle Behaviours, and Cognitive Function: A Multicohort Study. Lancet Healthy Longev. 2023, 4, e265–e273. [Google Scholar] [CrossRef]
- Global Age Distribution by Region 2023. Statista. Available online: https://www.statista.com/statistics/932555/Global-Population-by-Age-by-Continent/ (accessed on 11 July 2024).
- Saavedra-Moreno, C.; Hurtado, R.; Velasco, N.; Ramírez, A. Identification of Population Multimorbidity Patterns in 3.9 Million Patients from Bogota in 2018. Glob. Epidemiol. 2024, 8, 100171. [Google Scholar] [CrossRef]
- Keetile, M.; Navaneetham, K.; Letamo, G. Prevalence and Correlates of Multimorbidity among Adults in Botswana: A Cross-Sectional Study. PLoS ONE 2020, 15, e0239334. [Google Scholar] [CrossRef] [PubMed]
- López Ferreruela, I.; Obón Azuara, B.; Malo Fumanal, S.; Rabanaque Hernández, M.J.; Aguilar-Palacio, I. Gender Inequalities in Secondary Prevention of Cardiovascular Disease: A Scoping Review. Int. J. Equity Health 2024, 23, 146. [Google Scholar] [CrossRef] [PubMed]
- Kudesia, P.; Salimarouny, B.; Stanley, M.; Fortin, M.; Stewart, M.; Terry, A.; Ryan, B.L. The Incidence of Multimorbidity and Patterns in Accumulation of Chronic Conditions: A Systematic Review. J. Multimorb. Comorbidity 2021, 11, 26335565211032880. [Google Scholar] [CrossRef] [PubMed]
- WHO Mortality Database. Available online: https://Platform.Who.Int/Mortality/Countries/Country-Details/MDB/Lithuania?countryProfileId=b6fab8f3-9f75-4dd3-9cd0-B6aee45781fd (accessed on 22 January 2025).
- Sison, S.D.M.; Lin, K.J.; Najafzadeh, M.; Ko, D.; Patorno, E.; Bessette, L.G.; Zakoul, H.; Kim, D.H. Common Non-cardiovascular Multimorbidity Groupings and Clinical Outcomes in Older Adults with Major Cardiovascular Disease. J. Am. Geriatr. Soc. 2023, 71, 3179–3188. [Google Scholar] [CrossRef] [PubMed]
- Li, F.-R.; Wang, S.; Li, X.; Cheng, Z.-Y.; Jin, C.; Mo, C.-B.; Zheng, J.; Liang, F.-C.; Gu, D.-F. Multimorbidity and Mortality among Older Patients with Coronary Heart Disease in Shenzhen, China. J. Geriatr. Cardiol. 2024, 21, 81–89. [Google Scholar] [CrossRef]
- Ho, C.L.B.; Si, S.; Brennan, A.; Briffa, T.; Stub, D.; Ajani, A.; Reid, C.M. Multimorbidity Impacts Cardiovascular Disease Risk Following Percutaneous Coronary Intervention: Latent Class Analysis of the Melbourne Interventional Group (MIG) Registry. BMC Cardiovasc. Disord. 2024, 24, 66. [Google Scholar] [CrossRef]
- Tian, Y.; Li, D.; Cui, H.; Zhang, X.; Fan, X.; Lu, F. Epidemiology of Multimorbidity Associated with Atherosclerotic Cardiovascular Disease in the United States, 1999–2018. BMC Public Health 2024, 24, 267. [Google Scholar] [CrossRef]
- Mensah, G.A.; Fuster, V.; Murray, C.J.L.; Roth, G.A.; Mensah, G.A.; Abate, Y.H.; Abbasian, M.; Abd-Allah, F.; Abdollahi, A.; Abdollahi, M.; et al. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J. Am. Coll. Cardiol. 2023, 82, 2350–2473. [Google Scholar] [CrossRef]
- Canivell, S.; Muller, O.; Gencer, B.; Heg, D.; Klingenberg, R.; Räber, L.; Carballo, D.; Matter, C.; Lüscher, T.; Windecker, S.; et al. Prognosis of Cardiovascular and Non-Cardiovascular Multimorbidity after Acute Coronary Syndrome. PLoS ONE 2018, 13, e0195174. [Google Scholar] [CrossRef]
- Goldberg, R.; Chen, H.-Y.; Saczynski, J.; McManus, D.D.; Lessard, D.; Yarzebski, J.; Lapane, K. Gore the Impact of Cardiac and Noncardiac Comorbidities on the Short-Term Outcomes of Patients Hospitalized with Acute Myocardial Infarction: A Population-Based Perspective. Clin. Epidemiol. 2013, 5, 439–448. [Google Scholar] [CrossRef]
- Lawson, C.A.; Solis-Trapala, I.; Dahlstrom, U.; Mamas, M.; Jaarsma, T.; Kadam, U.T.; Stromberg, A. Comorbidity Health Pathways in Heart Failure Patients: A Sequences-of-Regressions Analysis Using Cross-Sectional Data from 10,575 Patients in the Swedish Heart Failure Registry. PLoS Med. 2018, 15, e1002540. [Google Scholar] [CrossRef] [PubMed]
- Tisminetzky, M.; Gurwitz, J.H.; Miozzo, R.; Gore, J.M.; Lessard, D.; Yarzebski, J.; Goldberg, R.J. Impact of Cardiac- and Noncardiac-Related Conditions on Adverse Outcomes in Patients Hospitalized with Acute Myocardial Infarction. J. Comorbidity 2019, 9, 2235042X19852499. [Google Scholar] [CrossRef] [PubMed]
- Suman, S.; Pravalika, J.; Manjula, P.; Farooq, U. Gender and CVD- Does It Really Matters? Curr. Probl. Cardiol. 2023, 48, 101604. [Google Scholar] [CrossRef] [PubMed]
- Suh, J.W.; Floud, S.; Reeves, G.K.; Cairns, B.J.; Wright, F.L. Multimorbidity of Cardiovascular Disease Subtypes in a Prospective Cohort of 1.2 Million UK Women. Open Heart 2023, 10, e002552. [Google Scholar] [CrossRef]
- Jin, L.; Guo, X.; Dou, J.; Liu, B.; Wang, J.; Li, J.; Sun, M.; Sun, C.; Yu, Y.; Yao, Y. Multimorbidity Analysis According to Sex and Age towards Cardiovascular Diseases of Adults in Northeast China. Sci. Rep. 2018, 8, 8607. [Google Scholar] [CrossRef]
- Tang, Z.; Wang, C.; Song, X.; Shi, J.; Mitnitski, A.; Fang, X.; Yu, P.; Rockwood, K. Co-Occurrence of Cardiometabolic Diseases and Frailty in Older Chinese Adults in the Beijing Longitudinal Study of Ageing. Age Ageing 2013, 42, 346–351. [Google Scholar] [CrossRef]
- Buja, A.; Rivera, M.; De Battisti, E.; Corti, M.C.; Avossa, F.; Schievano, E.; Rigon, S.; Baldo, V.; Boccuzzo, G.; Ebell, M.H. Multimorbidity and Hospital Admissions in High-Need, High-Cost Elderly Patients. J. Aging Health 2020, 32, 259–268. [Google Scholar] [CrossRef]
- Odland, M.L.; Ismail, S.; Sepanlou, S.G.; Poustchi, H.; Sadjadi, A.; Pourshams, A.; Marshall, T.; Witham, M.D.; Malekzadeh, R.; Davies, J.I. Multimorbidity and Associations with Clinical Outcomes in a Middle-Aged Population in Iran: A Longitudinal Cohort Study. BMJ Glob. Health 2022, 7, e007278. [Google Scholar] [CrossRef]
- Islam, M.M.; McRae, I.S.; Yen, L.; Jowsey, T.; Valderas, J.M. Time Spent on Health-related Activities by Senior Australians with Chronic Diseases: What Is the Role of Multimorbidity and Comorbidity? Aust. N. Z. J. Public Health 2015, 39, 277–283. [Google Scholar] [CrossRef]
- Chen, L.; Chan, Y.-K.; Busija, L.; Norekval, T.M.; Riegel, B.; Stewart, S. Malignant and Benign Phenotypes of Multimorbidity in Heart Failure: Implications for Clinical Practice. J. Cardiovasc. Nurs. 2019, 34, 258–266. [Google Scholar] [CrossRef]
Chronic Condition | ICD-10-AM 1 Diagnostic Codes | Speciality |
---|---|---|
Cancer | C00–C96 | Oncology |
Anaemia | D50 | Haematology |
Hypothyroidism | E02, E03, E89.0 | Endocrinology |
Diabetes | E10.0–E10.9, E11.01–E11.9 | Endocrinology |
Obesity | E66 | Endocrinology |
Dyslipidemia | E78 | Endocrinology |
Dementia | F00.0–F00.9, G30.0–G30.9; F01.0–F01.9; F02.0–F02.8; F03 | Neurology |
Mental disorders | F20.0–F20.9, F30.0–F39, F40.00–F40.9, F41.0–F51.9, F42.0–F42.9, F43.0–F43.9 | Psychiatry |
Parkinson disease | G20 | Neurology |
Multiple sclerosis | G35 | Neurology |
Epilepsy | G40.00–G40.91 | Neurology |
Sleep apnoea | G47.3 | Neurology |
Back pain | G54.1, G54.4, G55.1; M51 | Neurology |
Glaucoma | H40-H42 | Ophthalmology |
Blindness | H53-H54 | Ophthalmology |
Hearing loss | H90.0–H90.8; H91.0–H91.9 | Otolaryngology |
Hypertension | I10–I15 | Cardiology |
Ischemic heart disease | I20–I25 | Cardiology |
Heart failure | I50.0–I50.9 | Cardiology |
Intracranial bleeding | I60–I62 | Neurology |
Stroke | I63–I64; I69 | Neurology |
Chronic obstructive oulmonary disease | J44.0–J44.9, J96 | Pulmonology |
Asthma | J45.0–J45.9 | Pulmonology |
Inflammatory bowel disease | K50–K51 | Gastroenterology |
Psoriasis | L40.0–L40.9 | Dermatology |
Rheumatoid arthritis | M05–M06 | Rheumatology |
Gout | M10.0–M10.99 | Rheumatology |
Osteoarthritis | M15–M19 | Rheumatology |
Systemic lupus erythematosus | M32 | Rheumatology |
Osteoporosis | M80–M82 | Rheumatology |
Renal failure | N18–N19 | Nephrology |
Characteristics | All | Age Groups | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
18–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45–49 | 50–54 | 55–59 | 60–64 | 65–69 | 70–74 | 75–79 | 80+ | ||
General population *, n (%) | 2,315,914 (100) | 214,923 (9.3) | 179,708 (7.8) | 182,722 (7.9) | 177,297 (7.7) | 183,599 (7.9) | 203,762 (8.8) | 208,090 (9.0) | 226,832 (9.8) | 191,641 (8.3) | 158,515 (6.8) | 119,948 (5.2) | 115,436 (5.0) | 153,441 (6.6) |
Prevalence of at least one chronic condition 1,#, n (%) | 1,193,668 (51.5) | 28,567 (13.3) | 30,197 (16.8) | 38,788 (21.2) | 46,186 (26.1) | 65,374 (35.6) | 91,758 (45.0) | 117,300 (56.4) | 148,100 (65.3) | 141,850 (74.0) | 127,883 (80.7) | 106,652 (88.9) | 104,983 (90.9) | 146,030 (95.2) |
Median (Q1–Q3) of chronic conditions | 2 (1–3) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1 (1–2) | 1 (1–2) | 1 (1–2) | 2 (1–2) | 2 (1–3) | 2 (1–3) | 2 (1–3) | 2 (2–4) | 3 (2–4) | 3 (2–4) |
Female population #, n (%) | 1,275,019 (55.1) | 105,463 (49.1) | 88,809 (49.4) | 90,534 (49.5) | 89,351 (50.4) | 94,323 (51.4) | 105,521 (51.8) | 108,911 (52.3) | 122,364 (53.9) | 107,443 (56.1) | 94,409 (59.6) | 76,586 (63.8) | 77,086 (66.8) | 114,219 (74.4) |
Prevalence of women with at least one chronic condition 1,†, n (%) | 723,784 (56.8) | 15,681 (14.9) | 16,407 (18.5) | 20,564 (22.7) | 24,073 (26.9) | 33,625 (35.6) | 48,852 (46.3) | 66,047 (60.6) | 85,885 (70.2) | 84,458 (78.6) | 79,359 (84.1) | 69,413 (90.6) | 71,734 (93.1) | 107,686 (94.3) |
Male population #, n (%) | 1,040,895 (44.9) | 109,460 (50.9) | 90,899 (50.6) | 92,188 (50.5) | 87,946 (49.6) | 89,276 (48.6) | 98,241 (48.2) | 99,179 (47.7) | 104,468 (46.1) | 84,198 (43.9) | 64,106 (40.4) | 43,362 (36.2) | 38,350 (33.2) | 39,222 (25.6) |
Prevalence of men with at least one chronic condition 1,$, n (%) | 469,884 (45.1) | 12,886 (11.8) | 13,790 (15.2) | 18,224 (19.8) | 22,113 (25.1) | 31,749 (35.6) | 42,906 (43.7) | 51,253 (51.7) | 62,215 (59.6) | 57,392 (68.2) | 48,524 (75.7) | 37,239 (85.9) | 33,249 (86.7) | 38,344 (97.8) |
Characteristics | All | Number of Chronic Conditions | |||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5+ | |||
Number of patients, n (%) | 1,193,668 (100) | 476,282 (39.9) | 311,818 (26.1) | 190,771 (16.0) | 109,447 (9.2) | 105,350 (8.8) | |
Gender 1, n (%) | Women | 723,784 (60.6) | 269,999 (56.7) | 189,386 (60.7) | 121,681 (63.8) | 71,692 (65.5) | 71,026 (67.4) |
Men | 469,884 (39.4) | 206,283 (43.3) | 122,432 (39.3) | 69,090 (36.2) | 37,755 (34.5) | 34,324 (32.6) | |
Age (year) 2, mean ± SD | 60 ± 16 | 52 ± 17 | 61 ± 15 | 66 ± 13 | 69 ± 12 | 71 ± 11 | |
Number of hospitalizations per year 2, mean ± SD | 0.38 ± 0.87 | 0.21 ± 0.62 | 0.30 ± 0.76 | 0.44 ± 0.91 | 0.63 ± 1.06 | 1.00 ± 1.36 | |
Patients with at least one hospitalization per year 1, n (%) | 296,237 (24.8) | 75,220 (15.8) | 66,557 (21.3) | 55,889 (29.3) | 42,622 (38.9) | 55,949 (53.1) | |
The average length of stay per year 2, mean ± SD | 10.30 ± 13.74 | 7.88 ± 13.35 | 8.86 ± 12.62 | 10.03 ± 12.95 | 11.53 ± 13.39 | 14.62 ± 15.34 | |
Length of stay per year 1, n (%) | 1–3 | 98,274 (33.2) | 36,155 (48.1) | 26,053 (39.1) | 17,005 (30.4) | 10,101 (23.7) | 8960 (16.0) |
4–6 | 47,723 (16.1) | 12,554 (16.7) | 11,202 (16.8) | 9511 (17.0) | 6875 (16.1) | 7581 (13.5) | |
7+ | 150,240 (50.7) | 26,511 (35.2) | 29,302 (44.0) | 29,373 (52.6) | 25,646 (60.2) | 39,408 (70.4) | |
Number of rehospitalizations per year 2, mean ± SD | 0.24 ± 0.82 | 0.17 ± 0.70 | 0.20 ± 0.80 | 0.23 ± 0.83 | 0.28 ± 0.84 | 0.38 ± 0.95 | |
Patients with at least one rehospitalization per year 1, n (%) | 44,122 (14.9) | 7809 (10.4) | 7951 (11.9) | 7895 (14.1) | 7466 (17.5) | 13,001 (23.2) | |
Number of primary visits provided per year 2, mean ± SD | 9.25 ± 7.32 | 6.74 ± 5.62 | 8.95 ± 6.43 | 10.81 ± 7.33 | 12.54 ± 8.07 | 15.30 ± 9.80 | |
Number of specialist visits provided per year 2, mean ± SD | 6.52 ± 7.14 | 4.32 ± 5.25 | 6.08 ± 6.40 | 7.88 ± 7.34 | 9.53 ± 8.22 | 12.23 ± 9.81 |
Characteristics | Type of Multimorbidity | ||||
---|---|---|---|---|---|
≥2 Chronic Conditions | Complex Multimorbidity | Type of Complex Multimorbidity | |||
Complex Cardiac | Complex Non-Cardiac | ||||
Number of patients, n (%) | 717,386 (31.0) | 670,312 (28.9) | 569,732 (24.6) | 100,580 (4.3) | |
Gender 1, n (%) | Women | 453,785 (63.3) | 428,493 (63.9) | 362,274 (63.6) | 66,219 (65.8) |
Men | 263,601 (36.7) | 241,819 (36.1) | 207,458 (36.4) | 34,361 (34.2) | |
Age (year) 2, mean ± SD | 65 ± 14 | 65 ± 14 | 67 ± 13 | 55 ± 15 | |
Number of hospitalizations per year 2, mean ± SD | 0.49 ± 0.98 | 0.50 ± 1.00 | 0.51 ± 1.00 | 0.42 ± 0.95 | |
Patients with at least one hospitalization per year 1, n (%) | 221,017 (30.8) | 208,080 (31.0) | 180,881 (31.7) | 27,199 (27.0) | |
The average length of stay per year 2, mean ± SD | 11.13 ± 13.77 | 11.25 ± 13.94 | 11.39 ± 13.76 | 10.33 ± 15.09 | |
Length of stay per year 1, n (%) | 1–3 days | 62,119 (28.1) | 58,348 (28.0) | 48,205 (26.7) | 10,143 (37.3) |
4–6 days | 35,169 (15.9) | 32,702 (15.7) | 28,471 (15.7) | 4231 (15.6) | |
≥7 days | 123,729 (56.0) | 117,030 (56.2) | 104,205 (57.6) | 12,825 (47.2) | |
Number of rehospitalizations per year 2, mean ± SD | 0.27 ± 0.86 | 0.28 ± 0.87 | 0.28 ± 0.86 | 0.28 ± 0.97 | |
Patients with at least one rehospitalization 1 per year, n (%) | 36,313 (16.4) | 34,583 (16.6) | 30,606 (16.9) | 3977 (14.6) | |
Number of primary visits provided per year 2, mean ± SD | 10.92 ± 7.83 | 11.10 ± 7.91 | 11.18 ± 7.88 | 10.64 ± 8.03 | |
Number of specialist visits provided per year 2, mean ± SD | 7.99 ± 7.82 | 8.22 ± 7.92 | 7.95 ± 7.84 | 9.76 ± 8.18 |
Characteristics | Type of Multimorbidity (Ref. = Single Disease) | Univariate | Multivariate * | ||
---|---|---|---|---|---|
Count Part | Zero Part | Count Part | Zero Part | ||
IRR (95% CI) for the Number of Healthcare Utilization | OR (95% CI) for Having Healthcare Utilization | IRR (95% CI) for the Number of Healthcare Utilization | OR (95% CI) for Having Healthcare Utilization | ||
Hospitalizations per year | Non-complex | 1.17 (1.12, 1.22) | 2.02 (1.98, 2.06) | 1.08 (1.03, 1.13) | 1.79 (1.75, 1.83) |
Complex cardiac | 1.85 (1.82, 1.89) | 2.48 (2.46, 2.50) | 1.75 (1.71, 1.79) | 2.23 (2.21, 2.25) | |
Complex non-cardiac | 1.67 (1.62, 1.73) | 1.98 (1.95, 2.01) | 1.67 (1.62, 1.72) | 1.96 (1.93, 1.99) | |
Rehospitalizations per year | Non-complex | 0.47 (0.41, 0.53) | 1.33 (1.26, 1.41) | 0.49 (0.44, 0.56) | 1.17 (1.11, 1.24) |
Complex cardiac | 1.04 (0.99, 1.10) # | 1.76 (1.71, 1.81) | 1.12 (1.06, 1.19) | 1.60 (1.55, 1.64) | |
Complex non-cardiac | 1.52 (1.40, 1.64) | 1.48 (1.42, 1.54) | 1.56 (1.44, 1.69) | 1.47 (1.41, 1.53) | |
Primary visits provided per year | Non-complex | 1.25 (1.24, 1.26) | 1.23 (1.26, 1.31) | 1.34 (1.33, 1.34) | 1.58 (1.48, 1.69) |
Complex cardiac | 1.66 (1.66, 1.67) | 3.49 (3.37, 3.61) | 1.75 (1.75, 1.76) | 4.24 (4.09, 4.39) | |
Complex non-cardiac | 1.58 (1.57, 1.59) | 3.46 (3.22, 3.72) | 1.58 (1.57, 1.59) | 3.45 (3.21, 3.71) | |
Specialist visits provided per year | Non-complex | 1.04 (1.03, 1.05) | 1.25 (1.22, 1.28) | 1.11 (1.10, 1.12) | 1.75 (1.71, 1.80) |
Complex cardiac | 1.67 (1.67, 1.68) | 2.42 (2.40, 2.45) | 1.75 (1.74, 1.76) | 3.30 (3.27, 3.34) | |
Complex non-cardiac | 1.94 (1.93, 1.95) | 5.58 (5.42, 5.73) | 1.94 (1.92, 1.95) | 5.89 (5.73, 6.05) | |
Length of stay per year | Non-complex | 1.22 (1.18, 1.25) | 1.09 (1.06, 1.13) | ||
Complex cardiac | 1.56 (1.54, 1.58) | 1.43 (1.41, 1.45) | |||
Complex non-cardiac | 1.39 (1.36, 1.42) | 1.38 (1.35, 1.40) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ramanauskaitė, D.; Puronaitė, R.; Jakaitienė, A.; Glaveckaitė, S. Prevalence of Multimorbidity in Lithuania: Insights from National Health Insurance Fund Data. J. Cardiovasc. Dev. Dis. 2025, 12, 47. https://doi.org/10.3390/jcdd12020047
Ramanauskaitė D, Puronaitė R, Jakaitienė A, Glaveckaitė S. Prevalence of Multimorbidity in Lithuania: Insights from National Health Insurance Fund Data. Journal of Cardiovascular Development and Disease. 2025; 12(2):47. https://doi.org/10.3390/jcdd12020047
Chicago/Turabian StyleRamanauskaitė, Dovilė, Roma Puronaitė, Audronė Jakaitienė, and Sigita Glaveckaitė. 2025. "Prevalence of Multimorbidity in Lithuania: Insights from National Health Insurance Fund Data" Journal of Cardiovascular Development and Disease 12, no. 2: 47. https://doi.org/10.3390/jcdd12020047
APA StyleRamanauskaitė, D., Puronaitė, R., Jakaitienė, A., & Glaveckaitė, S. (2025). Prevalence of Multimorbidity in Lithuania: Insights from National Health Insurance Fund Data. Journal of Cardiovascular Development and Disease, 12(2), 47. https://doi.org/10.3390/jcdd12020047